|
|
regulation of defense response
|
GO:0031347 |
233 |
0.189
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.187
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.161
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.161
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.158
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.153
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.145
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.145
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.134
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.130
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.127
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.124
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.118
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.114
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.112
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.105
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.103
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.103
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.097
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.095
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.092
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.091
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.089
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.088
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.087
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.087
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.087
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.087
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.086
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.076
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.076
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.074
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.073
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.071
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.071
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.070
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.069
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.069
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.066
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.066
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.065
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.065
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.063
|
|
|
|
cellular response to peptidoglycan
|
GO:0071224 |
4 |
0.062
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.062
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.062
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.062
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.060
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.060
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.059
|
|
|
|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.058
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.058
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.054
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.054
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.054
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.053
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.053
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.051
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.051
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.051
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.051
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.050
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.050
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.050
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.050
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.050
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.049
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.049
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.048
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.048
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.047
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.046
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.046
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.046
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.045
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.044
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.044
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.044
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.044
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.043
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.043
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.042
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.042
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.041
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.041
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.040
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.040
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.040
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.040
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.040
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.039
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.037
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.037
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.037
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.036
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.035
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.035
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.034
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.034
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.034
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.033
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.033
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.033
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.032
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.032
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.032
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.032
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.031
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.031
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.030
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.030
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.030
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.030
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.030
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.030
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.029
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.029
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.029
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.029
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.028
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.028
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.028
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.028
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.028
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.028
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.027
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.027
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.027
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.027
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.027
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.027
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.026
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.026
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.026
|
|
|
|
serotonin secretion involved in inflammatory response
|
GO:0002442 |
4 |
0.026
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.026
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.026
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.026
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.026
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.025
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.025
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.025
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.025
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.025
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.025
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.024
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.024
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.024
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.024
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.024
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.024
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.024
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.024
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.024
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.024
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.024
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.024
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.024
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.024
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.023
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.023
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.023
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.023
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.023
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.023
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.023
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.023
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.023
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.023
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.023
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.023
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.023
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.023
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.022
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.022
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.022
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.022
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.022
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.022
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.022
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.022
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.022
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.021
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.021
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.021
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.021
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.021
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.021
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.021
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.021
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.021
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.021
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.021
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.020
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.020
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.020
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.020
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.020
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.020
|
|
|
|
response to molecule of fungal origin
|
GO:0002238 |
4 |
0.020
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.020
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.020
|
|
|
|
purinergic receptor signaling pathway
|
GO:0035587 |
7 |
0.020
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.020
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.020
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.019
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.019
|
|
|
|
regulation of mast cell activation
|
GO:0033003 |
21 |
0.019
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.019
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.019
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.019
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.019
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.019
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.019
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.019
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.019
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.019
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.019
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.019
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.019
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.019
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.019
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.018
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.018
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.018
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.018
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.018
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.018
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.018
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.018
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.018
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.018
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.018
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.018
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.018
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.018
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.018
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.018
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.018
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.018
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.017
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.017
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.017
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.017
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.017
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.017
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.017
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.017
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.017
|
|
|
|
toll like receptor 9 signaling pathway
|
GO:0034162 |
6 |
0.017
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.017
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.017
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.017
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.017
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.017
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.017
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.016
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.016
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.016
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.016
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.016
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.016
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.016
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.016
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.016
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.016
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.016
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.016
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.016
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.016
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.016
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.016
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.015
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.015
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.015
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.015
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.015
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.015
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.015
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.015
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.015
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.015
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.015
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.015
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.015
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.015
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.015
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.015
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.015
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.015
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.015
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.015
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.015
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.015
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.015
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.015
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.015
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.015
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.015
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.014
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.014
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.014
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.014
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.014
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.014
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.014
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.014
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.014
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.014
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.014
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.014
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.014
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.014
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.014
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.014
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.014
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.013
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.013
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.013
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.013
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.013
|
|
|
|
positive regulation of cytokine production involved in immune response
|
GO:0002720 |
19 |
0.013
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.013
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.013
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.013
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.013
|
|
|
|
positive regulation of interleukin 18 production
|
GO:0032741 |
2 |
0.013
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.013
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.013
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.013
|
|
|
|
serotonin production involved in inflammatory response
|
GO:0002351 |
4 |
0.013
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.013
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.013
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.013
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.013
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.013
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.013
|
|
|
|
serotonin transport
|
GO:0006837 |
11 |
0.012
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.012
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.012
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.012
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.012
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.012
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.012
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.012
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.012
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.012
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.012
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.012
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.012
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.012
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.012
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.012
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.012
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.012
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.012
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.012
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.012
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.012
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.012
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.012
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.012
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.012
|
|
|
|
positive regulation of toll like receptor 9 signaling pathway
|
GO:0034165 |
2 |
0.012
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.012
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.012
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.012
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.012
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.012
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.012
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.012
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.012
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.011
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.011
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.011
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.011
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.011
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.011
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
37 |
0.011
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.011
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.011
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.011
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.011
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.011
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.011
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.011
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.011
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.011
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.011
|
|
|
|
mast cell activation involved in immune response
|
GO:0002279 |
20 |
0.011
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.011
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.011
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.011
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.011
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.011
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.011
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.011
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.011
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.011
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.011
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.011
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.011
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.011
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.011
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.011
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.011
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.011
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.011
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.011
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.011
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.011
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.011
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.011
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.011
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.010
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.010
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.010
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.010
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.010
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.010
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.010
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.010
|
|
|
|
response to bacterial lipoprotein
|
GO:0032493 |
4 |
0.010
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.010
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.010
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.010
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.010
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.010
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.010
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.010
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.010
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.010
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.010
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.010
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.010
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.010
|
|
|
|
regulation of toll like receptor 9 signaling pathway
|
GO:0034163 |
3 |
0.010
|
|
